Loading...
Loading...
India's protein imports from UNITED STATES total $6.3M across 3,271 shipments from 15 foreign suppliers. R&D SYSTEMS INC leads with $1.9M in import value; the top 5 suppliers together control 65.9% of this origin. Leading Indian buyers include BI BIOTECH INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for protein — a diversified sourcing base with multiple active suppliers from UNITED STATES.

R&D SYSTEMS INC is the leading Protein supplier from UNITED STATES to India, with import value of $1.9M across 1,247 shipments. The top 5 suppliers — R&D SYSTEMS INC, ESPEE BIOPHARMA & FINECHEM LLC, LIFE TECHNOLOGIES CORPORATION, MONOBIND INC., ESPEE BIOPHARMA FINECHEM LLC — collectively account for 65.9% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | R&D SYSTEMS INC | $1.9M | 1,247 | 29.4% |
| 2 | ESPEE BIOPHARMA & FINECHEM LLC | $1.2M | 5 | 19.6% |
| 3 | LIFE TECHNOLOGIES CORPORATION | $416.1K | 107 | 6.6% |
| 4 | MONOBIND INC. | $376.6K | 6 | 6.0% |
| 5 | ESPEE BIOPHARMA FINECHEM LLC | $276.1K | 3 | 4.4% |
| 6 | R D SYSTEMS INC | $255.4K | 232 | 4.0% |
| 7 | R & D SYSTEMS, INC. | $242.9K | 203 | 3.8% |
| 8 | ATHENS RESEARCH & TECHNOLOGY | $133.9K | 12 | 2.1% |
| 9 | CELTIS HEALTHCARE LLC | $130.3K | 1 | 2.1% |
| 10 | SPRING BIO SOLUTION. | $128.8K | 1 | 2.0% |
| 11 | R D SYSTEMS, INC. | $116.0K | 111 | 1.8% |
| 12 | R&D SYSTEMS, INC. | $111.2K | 61 | 1.8% |
| 13 | R & D SYSTEMS INC. | $76.0K | 50 | 1.2% |
| 14 | PIERCE BIOTECHNOLOGY,INC. | $71.3K | 177 | 1.1% |
| 15 | AGRACE PHARMA | $56.1K | 3 | 0.9% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | BI BIOTECH INDIA PRIVATE LIMITED | $1.6M | 951 | 25.5% |
| 2 | DR.REDDY'S LABORATORIES LIMITED | $1.0M | 1 | 16.2% |
| 3 | INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED | $522.6K | 346 | 8.3% |
| 4 | TULIP DIAGNOSTICS PRIVATE LIMITED | $431.1K | 15 | 6.8% |
| 5 | MYLAN LABORATORIES LIMITED | $348.9K | 5 | 5.5% |
| 6 | AGILE DIAGNOSTICS | $262.0K | 223 | 4.2% |
| 7 | INTAS PHARMACEUTICALS LIMITED | $253.1K | 2 | 4.0% |
| 8 | AIC ENTERPRISES PRIVATE LIMITED | $245.7K | 315 | 3.9% |
| 9 | MSP LAB INSTRUMENTS PRIVATE LIMITED | $197.7K | 119 | 3.1% |
| 10 | YASHRAJ BIOTECHNOLOGY LIMITED | $131.1K | 15 | 2.1% |
| 11 | CIPLA LIMITED | $128.8K | 1 | 2.0% |
| 12 | CHEMSIS ENTERPRISES | $126.4K | 98 | 2.0% |
| 13 | A.I.C. SPECIALITIES | $117.7K | 134 | 1.9% |
| 14 | MSP LAB INSTRUMENTS | $113.5K | 76 | 1.8% |
| 15 | SYNGENE INTERNATIONAL LIMITED | $69.4K | 30 | 1.1% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Protein suppliers from UNITED STATES to India include R&D SYSTEMS INC, ESPEE BIOPHARMA & FINECHEM LLC, LIFE TECHNOLOGIES CORPORATION. The leading supplier is R&D SYSTEMS INC with import value of $1.9M USD across 1247 shipments. India imported Protein worth $6.3M USD from UNITED STATES in total across 3,271 shipments.
India imported Protein worth $6.3M USD from UNITED STATES across 3,271 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Protein sourced from UNITED STATES include BI BIOTECH INDIA PRIVATE LIMITED, DR.REDDY'S LABORATORIES LIMITED, INVITROGEN BIOSERVICES INDIA PRIVATE LIMITED. The largest buyer is BI BIOTECH INDIA PRIVATE LIMITED with $1.6M in imports across 951 shipments.
The total value of Protein imports from UNITED STATES to India is $6.3M USD, across 3,271 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,271 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists